✦ LIBER ✦

55 Intravenous busulfan conditioning prior to allogeneic hematopoietic stem cell transplantation: Myeloablation with reduced toxicity

✍ Scribed by A. Shimoni; B. Bielorai; A. Toren; I. Hardan; A. Avigdor; M. Yeshurun; I. Ben-Bassat; A. Nagler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravenous busulfan-based conditioning

✍ Avichai Shimoni; Bella Bielorai; Amos Toren; Izhar Hardan; Abraham Avigdor; Mosh 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Comparison of Intravenous with Oral Busu

✍ Kato, Motohiro; Takahashi, Yoshiyuki; Tomizawa, Daisuke; Okamoto, Yasuhiro; Inag 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Reduced-toxicity conditioning with fluda

✍ Trenschel, R; Andreesen, R; Stuhler, G; Einsele, H; Kanz, L; Keilholz, U; Marine 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 147 KB

Intravenous busulfan versus melphalan-ba

✍ A. Shimoni; I. Hardan; M. Yeshurun; A. Avigdor; A. Papatryphonos; F.I. Tsolakis; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Pharmacokinetic targeting of intravenous

✍ Joseph Pidala; Jongphil Kim; Claudio Anasetti; Mohamed A Kharfan-Dabaja; Taiga N 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 484 KB

Lower incidence of Bronchiolitis obliter

✍ Yoshihara, S; Tateishi, U; Ando, T; Kunitoh, H; Suyama, H; Onishi, Y; Tanosaki, 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB